| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |